National Research Corporation
NASDAQ:NRCMedical - Healthcare Information Services
+$0.07 today
- Market cap
- $555.16M
- Beta
- 0.40
- P/E (TTM)
- 43.0
- EPS (TTM)
- $0.41
- Dividend yield
- 3.14%
Volume 0.09M
Average 0.11M
NRC Operating Cash Flow
Cash generated by the company's core business operations during the period.
National Research CorporationNASDAQ: NRC
Operating Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Operating cash flow growth accelerates
Q1 FY2026 operating cash flow of $7.18M rose 8.0% year over year, ahead of the -7.7% change in trailing-twelve-month operating cash flow. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at -10.0% a year.
Context
- Operating cash flow amounted to 19.3% of revenue in FY2025, down 5.0 pp from a year earlier.
- Operating cash flow increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +8.0% holds above the trailing-twelve-month pace of -7.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Operating Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 26.45M USD
- Year-over-year change
- -23.6%
- 4-year CAGR
- -13.1%
| Period | Period end | Operating Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 26.45M | -23.6% |
| FY2024 | 2024-12-31 | 34.63M | -9.2% |
| FY2023 | 2023-12-31 | 38.11M | +5.1% |
| FY2022 | 2022-12-31 | 36.27M | -21.7% |
| FY2021 | 2021-12-31 | 46.34M | — |
Operating Cash Flow vs competitors
How NRC compares with its peers on the latest reported figures
- NRC's LTM Mar 2026 operating cash flow of $26.98M is the 7th largest of the 8 companies compared; the peer median is $39.28M.
- Its year-over-year change of -7.7% is the 7th highest of 8, against a peer median of +24.8%.
- Operating cash flow amounts to 19.5% of revenue for NRC, versus a peer median of 17.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
CTEVClaritev Corporation | LTM Mar 2026 | $98.74M | +262.6% | -32.0% | 10.1% |
| LTM Apr 2026 | $85.63M | +78.6% | — | 17.3% | |
| LTM Mar 2026 | $63.38M | -0.7% | +7.3% | 20.3% | |
| LTM Mar 2026 | $42.12M | +8.2% | -18.5% | 51.9% | |
| LTM Mar 2026 | $39.28M | -42.0% | +14.8% | 16.5% | |
| LTM Mar 2026 | $27.06M | +24.8% | +10.5% | 21.8% | |
| LTM Mar 2026 | $26.98M | -7.7% | -10.0% | 19.5% | |
| LTM Mar 2026 | $18.96M | +314.7% | — | 6.3% | |
| Peer median (excluding NRC) | $39.28M | +24.8% | +7.3% | 17.3% | |
Competitors are the stored peer set for NRC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 37.47M | 31.8M | 30.97M | 24.78M | 11.6M |
| Depreciation & Amortization | 6.37M | 5.28M | 5.9M | 6.02M | 7.62M |
| Deferred Income Tax | 33K | (1.24M) | (717K) | (406K) | 2.45M |
| Stock-Based Compensation | 623K | 1.2M | 935K | 284K | 3.31M |
| Change in Working Capital | 1.84M | (3.35M) | 1.03M | 3.84M | 916K |
| Accounts Receivables | 343K | (733K) | 2.08M | 1.76M | (53K) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 4K | (589K) | 184K | (108K) | 170K |
| Other Working Capital | 1.49M | (2.03M) | (1.24M) | 2.19M | 799K |
| Other Non-Cash Items | 7K | 2.58M | (102K) | 100K | 545K |
| Operating Cash Flow | 46.34M | 36.27M | 38.11M | 34.63M | 26.45M |
| Capital Expenditures | (5.51M) | (9.84M) | (15.78M) | (15.45M) | (10.71M) |
| Acquisitions (Net) | (3M) | 0 | 0 | (4.83M) | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 1K | 0 | 0 |
| Investing Cash Flow | (8.51M) | (9.84M) | (15.78M) | (20.28M) | (10.71M) |
| Debt Repayment | (4.59M) | (4.77M) | 14.18M | 25.99M | 16.11M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 132K |
| Common Stock Repurchased | (4.14M) | (27.62M) | (19.1M) | (30.95M) | (20.18M) |
| Dividends Paid | (9.16M) | (20.96M) | (36.37M) | (11.45M) | (10.98M) |
| Other Financing Activities | (275K) | (2.04M) | 576K | (359K) | (923K) |
| Financing Cash Flow | (18.16M) | (55.58M) | (40.71M) | (16.76M) | (15.84M) |
| Effect of Forex Changes | 3K | (182K) | (1K) | 0 | 0 |
| Net Change in Cash | 19.67M | (29.34M) | (18.37M) | (2.42M) | (94K) |
| Free Cash Flow | 40.83M | 26.43M | 22.33M | 19.18M | 15.74M |
National Research Corporation
NASDAQ:NRC
Intrinsic Alpha fair value
Locked
Current Price
$26.16
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.